Axsome Therapeutics
AXSM
AXSM
349 hedge funds and large institutions have $4.32B invested in Axsome Therapeutics in 2025 Q1 according to their latest regulatory filings, with 91 funds opening new positions, 101 increasing their positions, 114 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
349
Holders Change
+59
Holders Change %
+20.34%
% of All Funds
4.74%
Holding in Top 10
12
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+9.09%
% of All Funds
0.16%
New
91
Increased
101
Reduced
114
Closed
29
Calls
$111M
Puts
$86.5M
Net Calls
+$24.5M
Net Calls Change
-$35M
Top Buyers
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$72.7M |
| 2 |
D.E. Shaw & Co
New York
|
+$61.5M |
| 3 |
O
OrbiMed
New York
|
+$45.1M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$42.4M |
| 5 |
Man Group
London,
United Kingdom
|
+$40.8M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
N
376
Natixis
Paris,
France
| – | -$63.3K | -748 | Closed |
|
|
ACM
377
Aster Capital Management
Dubai,
United Arab Emirates
| – | -$10.8K | -128 | Closed |
|
378
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$2.62K | -31 | Closed |
|